4.8 Article

Developmental Consequences of Defective ATG7-Mediated Autophagy in Humans

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 384, Issue 25, Pages 2406-2417

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMoa1915722

Keywords

-

Funding

  1. MRC [G0800674] Funding Source: UKRI
  2. European Commission [BMBF 01GM1607] Funding Source: Medline
  3. Medical Research Council [G0800674, G0502157, G0400074, G0900652, G1100540, MR/S005021/1, MR/N008324/1] Funding Source: Medline
  4. Wellcome Trust [203105] Funding Source: Medline
  5. Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung [320030_179547] Funding Source: Medline
  6. Swiss National Science Foundation (SNF) [320030_179547] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

This study identified several patients with neurodevelopmental disorders who survived with severe loss or complete absence of ATG7, an essential effector enzyme for autophagy without a known functional paralogue.
Background Autophagy is the major intracellular degradation route in mammalian cells. Systemic ablation of core autophagy-related (ATG) genes in mice leads to embryonic or perinatal lethality, and conditional models show neurodegeneration. Impaired autophagy has been associated with a range of complex human diseases, yet congenital autophagy disorders are rare. Methods We performed a genetic, clinical, and neuroimaging analysis involving five families. Mechanistic investigations were conducted with the use of patient-derived fibroblasts, skeletal muscle-biopsy specimens, mouse embryonic fibroblasts, and yeast. Results We found deleterious, recessive variants in human ATG7, a core autophagy-related gene encoding a protein that is indispensable to classical degradative autophagy. Twelve patients from five families with distinct ATG7 variants had complex neurodevelopmental disorders with brain, muscle, and endocrine involvement. Patients had abnormalities of the cerebellum and corpus callosum and various degrees of facial dysmorphism. These patients have survived with impaired autophagic flux arising from a diminishment or absence of ATG7 protein. Although autophagic sequestration was markedly reduced, evidence of basal autophagy was readily identified in fibroblasts and skeletal muscle with loss of ATG7. Complementation of different model systems by deleterious ATG7 variants resulted in poor or absent autophagic function as compared with the reintroduction of wild-type ATG7. Conclusions We identified several patients with a neurodevelopmental disorder who have survived with a severe loss or complete absence of ATG7, an essential effector enzyme for autophagy without a known functional paralogue. (Funded by the Wellcome Centre for Mitochondrial Research and others.) Genetic Deficit in the Cellular Sanitation System Autophagy is a cellular process through which toxic aggregates, pathogens, and damaged organelles are disposed of and essential metabolites recycled. This study challenges the belief that a core autophagy protein is indispensable.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available